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Abstract
Background: Compliance with CPAP treatment for OSAS is not reliably predicted by the severity of symptoms or
physiological variables. We examined a range of factors which could be measured before CPAP initiation to look for
predictors of compliance.
Methods: This was a prospective cohort-study of CPAP treatment for OSAS, recording; socio-economic status,
education, type D personality and clinician’s prediction of compliance.
Results: We recruited 265 subjects, of whom 221 were still using CPAP at 6 months; median age 53 years, M: F, 3.4:
1, ESS 15 and pre-treatment ODI 21/h. Median compliance at 6 months was 5.6 (3.4– 7.1) hours/night with 73.3% of
subjects using CPAP ≥4 h/night. No association was found between compliance and different socio-economic
classes for people in work, type D personality, education level, sex, age, baseline ESS or ODI. The clinician’s initial
impression could separate groups of good and poor compliers but had little predictive value for individual patients.
Compared to subjects who were working, those who were long term unemployed had a lower CPAP usage and
were more likely to use CPAP < 4 h a night (OR 4.6; p value 0.011). A high Beck Depression Index and self-reported
anxiety also predicted poor compliance.
Conclusions: In our practice there is no significant association between CPAP compliance with socio-economic
status, education or personality type. Long term unemployed or depressed individuals may need more intensive
support to gain the optimal benefit from CPAP.
Keywords: Obstructive sleep apnoea, CPAP compliance, Socio-economic status, Unemployed, Depression, Type D
personality, Physician’s prediction
Background
Obstructive sleep apnoea syndrome (OSAS) is a com-
mon condition, which can lead to low health status [1]
through sleepiness, poor concentration and marital dis-
cord [2]. It increases the likelihood of accidents includ-
ing road traffic collisions [3] and is probably an
independent risk factor for cardiovascular mortality and
morbidity [4, 5]. Continuous positive airway pressure
(CPAP) treatment can reverse daytime sleepiness and in
case controlled series is associated with a fall in the
number of car crashes and the incidence of strokes and
heart attacks [6–8]. The benefit on a number of symptom
measures is proportional to the amount of time spent
using CPAP [9]. In some series that reported a reduction
in cardiovascular disease with CPAP the comparator
group with worse outcomes comprised non-acceptors of
CPAP [10]. Compliance with CPAP is therefore key to its
effectiveness. Initial acceptance of treatment has been
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reported to be as good as 84% [11] but historical series
have reported that as few as 46% of initial acceptors subse-
quently used CPAP for more than 4 h/night [12]. In more
recent studies of interventions to improve compliance the
use of CPAP has been found to range between 2 to 8 h
[13]. Given the large number of patients treated with
CPAP a significant number of symptomatic OSA patients
are still left with suboptimal usage.
The initial pattern of compliance is one of the better
predictors of long-term use [14]. Interventions that are
directed at increasing compliance may be costly [15].
For both of these reasons, it would be most helpful if cli-
nicians could identify the patients who are likely to fail
to comply well with treatment before it is initiated, to
focus interventions at the start of treatment in those
most likely to need extra support. There have been stud-
ies investigating associations with poor compliance. Sev-
eral have reported the impact of nasal and pressure
related side effects, but these only become apparent after
a period of treatment. The severity of OSA has been
shown to have predictive value in some [16] but not all
studies [17]. Recent reports have shown associations for
both low socio-economic group [18–21] and type D per-
sonality (the tendency to suppress emotional distress)
[22] with poor compliance though the latter was retro-
spective. The physician’s ability to predict which patients
will be good and poor compliers with CPAP has not
been extensively investigated. More recent published
work supported adopting a common sense patient
centred approach, assessing medical, technical and be-
havioural factors in improving CPAP compliance [23].
We conducted this prospective study in newly diag-
nosed OSAS patients to determine which socio-economic
and personality factors identified before the initiation of
CPAP might be associated with lower rates of initial ac-
ceptance and sub-optimal long-term compliance with the
therapy.
This study was approved by the Cambridgeshire 1 re-
search and ethics committee (08/H0304/72).
Methods
All individuals referred to a specialist respiratory support
and sleep centre and seen initially in our outpatient
clinic with suspected OSAS were considered for the
study. The diagnosis of OSAS was established on the
basis of interview with a sleep specialist and overnight
oximetry showing an ODI ≥ 10 per hour. Multi-channel
respiratory sleep studies or polysomnography (PSG)
were performed if patients with a history strongly
suggestive of OSAS had an ODI < 10 per hour or pa-
tients had an ODI > 10 per hour and a cardio-respiratory
or neurological condition which might produce nocturnal
hypoxemia or cause central apnoea or Cheyne - Stokes
respiration.
Patients who had a diagnosis of OSAS confirmed and
were considered for CPAP treatment were approached
to participate in the study. After informed consent sub-
jects completed a range of questionnaires as described
below. The following factors were examined looking for
their association with CPAP compliance:
Primary factors
 Socio-economic status – derived by national
statistics socio-economic classification (NS-SEC),
self coded version [24]. The self-coded version of the
national statistics socioeconomic classification was
used to assess SEC. This scale takes into account; an
individual’s occupational and employment status,
size of the employing organisation, self-employed vs.
employee, managerial vs. no supervisory role and
allocates individuals to one of 6 classes (one class
being long term unemployed).
 Type D personality – also known as distressed
personality, reflects an individual’s ability to suppress
emotions. This was assessed using a validated tool
(DS-14 scale) comprising 7 questions related to
negative affectivity or social inhibition [25].
Secondary factors
 The physician’s estimate of the likelihood that the
patient would accept CPAP treatment and
subsequently comply with the treatment.
 Depression – assessed by Beck’s depression
inventory 2 (BDI-2). An existing diagnosis of
depression was noted. All subjects completed a
BDI-2 questionnaire. Those with a score < 13 were
classified as normal, 14–19 mild depression, 20–28
moderate depression, and 29–63 severe depression.
It is noted that this tool is designed to assess the
severity of depression and is not intended as a
diagnostic tool
 Anxiety - self report of previous diagnosis.
 The patient’s sex
 Level of education- Educational history was
categorised as no formal qualification, school
certificate, higher school certificate or bachelor degree.
 Sleep specific quality of life scores (sleep apnoea
quality of life index-SAQLI) score.
 Epworth sleepiness scale score (ESS)
 Severity of OSA as assessed by 4% oxygen
desaturation index (ODI).
The physician who assessed the patient in clinic esti-
mated the likelihood of the patient accepting the treatment
and continuing to use CPAP for > 4 h/night, expressed as a
percentage on a visual analogue scale (from 0 to 100). The
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estimates were based on their impression after reviewing
the patient for the first time in clinic and assessing the ini-
tial response of patients to the offer of CPAP treatment.
The investigators did not ask the clinicians to consider any
particular information when evaluating the likelihood of
acceptance and compliance with CPAP. The physicians
marking the visual analogue scale had from 2 to 25 years
of experience in managing sleep disorders.
After consenting to participate in the study, patients
were admitted for overnight manual titration with CPAP.
Treatment was commenced at a single centre and stand-
ard local titration protocols were followed. Next day, pa-
tients were discharged on a fixed pressure CPAP device,
with the pressure having been determined from the titra-
tion night. Choice of mask (nasal vs. full face vs. total
face) and humidification usage was influenced by patient
choice and comfort, rather than unselective use of either.
All the patients had access to the sleep physiologist for a
mask or humidification review if needed. This approach
potentially reduced the selection bias and was more in
keeping with real life clinical management of OSAHS
with CPAP.
During subsequent follow-up at 6–10 weeks and
6 months; SAQLI and BDI-2 scores were repeated.
Additional questions were asked to assess the individ-
ual’s experience of CPAP treatment.
Outcome measures
Individuals who used CPAP and were still using it at sec-
ond follow-up appointments up to 6 months were desig-
nated acceptors. CPAP compliance was measured using
an inbuilt counter in the CPAP machine, during the
follow-up visits at 6–10 weeks and 6 months. Average
CPAP use of less than 4 h/night was considered sub-
optimal compliance.
Statistical analysis
Using the socio-economic status variable, it was esti-
mated that 240 patients would give a predictive power
to detect a one hour difference in compliance between
the different groups. When the results were analysed
most of the variables were found to be non-normally
distributed and groups were compared using the non-
parametric Mann–Whitney U test. To assess the ability
of the physician’s confidence that the subject would use
CPAP to predict compliance, receiver operator charac-
teristic (ROC) analysis was performed.
Results
The study recruited over a period of 7 months. In this
period 566 patients were initiated on CPAP therapy in
the sleep centre, 410 of whom were first seen in clinic
and were therefore available for the study. Of these, 265
consented to participate in the study. There were 205
men (male to female ratio 3.4:1). Expressed as medians
(IQR) the age of participants was 53.0 (44–61) years,
ESS 15.0 [11–17], BMI 34.8 (31.6- 41.7) kg/m2, ODI
21.0 (12.3- 41.2) per hour. Type D personality was found
in 120 (45%) subjects. At baseline 31.7% were on antide-
pressants or said that they had previously been diag-
nosed with depression by their general practitioner and
44.6% of subjects had a BDI-2 score of > 13.
From the cohort of 265 subjects, 9 were switched to a
bi-level device, 5 were excluded (one was diagnosed with
an upper airway malignancy, another was cured of OSA
by tonsillectomy, 3 did not attend any follow-up visit
during the study period), 5 withdrew consent. The initial
acceptance was calculated as the proportion of individ-
uals still using CPAP after 6 months. Two hundred and
twenty one study subjects (89.8%) were still using CPAP
at 6 months. There was a strong correlation between the
early compliance measured as hours of use at first
follow-up, (6–10 weeks) and 6 months compliance with
CPAP (r = 0.77) (Fig. 1). The median use at first follow
up and 6 months were, 6.0 (4.2-7.5) and 5.6 (3.4- 7.1)
hours/night respectively. By our definition of < 4 h/night,
19.0% were using CPAP sub-optimally at first visit and
26.7% at 6 months.
The distribution of different SEC categories within the
study population is shown in Table 1. The hours of use
in each SEC category at first follow up and at 6 months
is shown in Fig. 2a and b respectively. Compared to indi-
viduals who were working (or retired from work), those
who were long term unemployed had lower median
hours of CPAP usage at first follow up and at 6 months
(Table 2). This group was also more likely to use CPAP
sub-optimally (<4 h/night) at first follow up visit and at
6 months (OR 3.3, and OR 4.6 respectively, see Table 3).
Fig. 1 Correlation between early (6–10 weeks) and late CPAP
compliance (6 months)
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The diagnosing physicians in clinic who recommended
the use of CPAP treatment correctly allocated higher
and lower likelihoods of compliance to the good and
poor complier populations. The group who used CPAP
for ≥4 h/night at first visit, were given a likelihood of
good compliance of 81%, while those who used CPAP <
4 h/night were given a likelihood of 71%. The difference
persisted at 6 months. We looked for a specific cut off
point for a physician’s initial impression to predict sub-
optimal compliance. Though the sensitivity of predicting
suboptimal compliance was 82.5% and specificity 91.1%,
when a physician marked ≤ 60% on a visual analogue
scale, on ROC analysis area under the curve was only
0.59 (Fig. 3).
At 6 months, the median compliance in individuals
with an elevated BDI 2 score (>13) was 5.0 (IQR 2.6 – 7.4)
hours/night which was non-significantly lower than the
6.0 (IQR 4.7 – 7.0) hours/night for those whose BDI score
was ≤ 13 (Table 2). This difference became more marked
for those with BDI score ≥ 29 and was statistically signifi-
cant (p = 0.028). Current symptoms as measured by a
raised BDI predicted poor compliance with CPAP;
whereas an existing (and in many cases treated) diagnosis
of depression did not. Depression was more common in
the subjects who were unemployed and if they were ex-
cluded from the analysis there was no longer an associ-
ation between poor compliance and depression. Self
reported anxiety on enrolment to the study also predicted
lower hours of use CPAP (Table 2). There was a non-
significant trend for individuals with type D personality to
comply sub-optimally at 6 months, compared to those
who were non-type D. No association was found between
hours of use either at first or 6 month follow up and sex,
age, baseline ESS, or ODI (Table 2).
Discussion
CPAP treatment for Obstructive sleep apnoea syndrome
is rapidly effective with sleepiness and other symptoms
best controlled in those who use CPAP for the highest
number of hours [6, 8, 9, 26]. It will be best clinical
practice and use of resources to identify patients who
are likely to have sub-optimal compliance and concen-
trate interventions to improve usage on those people. In
the current study SEC for those in work, level of educa-
tion and personality type, the severity of sleep apnoea
measured by ESS or by ODI, were not good predictors.
Our study has shown that the Gestalt impression of the
prescribing physician can predict to an extent which pa-
tients will be good and less good compliers. Less oper-
ator dependent measures, which differentiated these
patients at presentation were employment status and a
diagnosis of depression.
To date there have been few studies looking at the role
of socio-economic status in acceptance and compliance
with CPAP treatment in patients with OSAHS. One
cross sectional study looking at the pattern of adherence
and acceptance of CPAP in an Israeli population found
the likelihood of CPAP purchase to be determined by in-
come level [19]. Only 21.8% of individuals with low in-
come accepted and purchased CPAP compared to 51.4%
Table 1 Distribution between different socio-economic status







Long term unemployed- not working 19 (7.2%)
Missing 15 (5.7%)
Fig. 2 Hours of CPAP use in different socioeconomic class. a
Socioeconomic class vs. CPAP compliance at first visit. b Socioeconomic
class vs. CPAP compliance at 6 month
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from average and 75.6% from higher income groups.
Twenty nine percent of those who declined CPAP cited
cost as the reason. In our study no difference in the
average compliance or the proportion of people using
CPAP sub-optimally, was seen in relation to different
socio economic class for those in work. CPAP was pro-
vided free of charge at the point of delivery making in-
come level unlikely to be a determinant. There was
however significantly lower compliance in individuals
who were long term unemployed compared to the ones
who were in work with an odds ratio of 4.6 for sub-
optimal compliance at 6 months. The number of
unemployed individuals was small (19 at the start of the
study), and this result may not be generalizable. How-
ever, the number of long term unemployed people in the
study reflected the unemployment rate in the UK at the
time of the study. A study done in a health care system
similar to ours found no difference in the compliance
between individuals depending on socio-economic back-
ground assessed by educational status [27].
Individuals who have high negative affectivity and so-
cial inhibition, are classed as Type D personality [25].
Negative emotions in these individuals are likely to be
associated with self-neglect with possible implications of
Table 2 Median hours of use for subjects using CPAP in different sub groups defined by study characteristics
First follow-up (6–10 weeks) 6 month follow-up
Median hours of use (IQR) per night P value Median hours of use (IQR) per night P value
Long term unemployed vs.
people in work (or retired)
4.2 (3.8–5.3) vs. 6.3 (4.3– 7.5) 0.028 2.61 (1.0 – 5.7) vs. 5.96 (4.0– 7.2) 0.016
Education : Bachelor degree
vs. less, formal education
6.04 (4.14–7.49) vs. 5.90 (4.53–7.42) 0.61 5.75 (3.4–7.13) vs. 6.02 (5.01–7.1) 0.35
Type D personality; vs. Non-Type D 6.00 (4.2–7.22) vs. 6.07 (4.22–7.49) 0.8 5.5 (2.9–7.1) vs. 6.06 (4.14–7.1) 0.48
Previous diagnosis of depression vs. None 6.87 (2.92–7.85) vs. 6.00 (4.22– 7.17) 0.19 5.61(3.00–6.90) vs. 5.74 (3.99–7.10) 0.7
BDI > 13 vs. ≤ 13 6.00 (4.14–7.65) vs. 6.15 (4.36–7.26) 0.62 5.01(2.62–7.37) vs. 5.99 (4.68–7.00) 0.57
BDI≥ 29 vs. BDI <29 4.72 (4.30–7.49) vs. 6.20 (3.98–7.19) 0.31 4.27 (2.52–6.5) vs. 5.98 (4.01–7.13) 0.08
Anxiety vs. No anxiety (self report) 6.46(3.77–7.87) vs. 6.00 (4.22 –7.22) 0.25 5.01 (2.56–6.66) vs. 5.84(4.0–7.20) 0.09
Sex (male vs. female) 6.00 (4.2–7.2) vs. 6.36 (4.18–7.19) 0.43 5.59 (3.4–7.03) vs. 5.97 (4.75–7.6) 0.26
Age (greater than 70 vs. ≤70 years) 7.02 (6.6– 7.23) vs. 6.00 (4.1–7.46) 0.21 6.99 (5.94–7.00) vs. 5.61 (3.4–7.1) 0.23
ESS≥ 10 vs. <10 6.02 (4.14–7.45) vs. 6.0 (4.63–7.73) 0.24 5.6 (3.4–7.1) vs. 6.1 (4.17–7.2) 0.20
4% desaturation index >20 vs. ≤20 per hour 6.0 (4.1–7.5) vs. 6.04 (4.16–7.38) 0.8 6.14 (3.62–7.27) vs. 5.39 (3.2–6.99) 0.38
Table 3 Distribution of subjects using CPAP for equal to/more than, or less than 4 h per night by study characteristics
First follow-up (6–10 weeks) 6 month follow-up OR for suboptimal
compliance at six months
(95% confidence interval)
Percentage with characteristic
and compliance ≤ 4 h/night




Long term unemployed vs. people
in work (or retired)
45% vs. 19% 0.046 64% vs. 26% 0.011 4.59 (1.4-15.0)
Education: Bachelor degree vs. less,
formal education
22.2% vs. 12.9% 0.18 29.3% vs. 16.3% 0.09 1.12 (0.99-1.28)
Type D personality vs. non-Type D 21% vs. 19% 0.40 33% vs. 22% 0.056 1.30 (0.93-1.72)
Previous diagnosis of depression
vs. None
27% vs. 18% 0.088 34% vs. 25% 0.10 1.34 (0.91-1.99)
BDI > 13 vs. ≤ 13 24% vs. 18% 0.28 34% vs. 21% 0.03 1.40 (1.03-1.9)
BDI≥ 29 vs. BDI <29 29% vs. 19% 0.24 50% vs. 25% 0.028 2.65 (1.12-6.3)
Anxiety vs. No anxiety
(self report)
30% vs. 19% 0.052 40% vs. 25% 0.048 1.67 (0.99-2.84)
Sex (male vs. female) 20.5% vs. 23.8% 0.39 30.2% vs. 20.5% 0.14 1.68 (0.75-3.77)
Age (greater than 70 vs. ≤70 years) 22.2% vs. 0% 0.32 29.9% vs. 0% 0.19 1.04 (1.0-1.07)
ESS≥ 10 VS < 10 29% vs. 16% 0.24 29.3% vs. 19.2% 0.20 1.07 (0.96-1.18)
4% desaturation index >20 vs. ≤20
per hour
20% vs. 23% 0 .34 28% vs. 30% 0.47 1.04 (0.76-1.4)
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poor adherence to treatment. A retrospective study pre-
viously described that compliance in those with Type D
personality was on an average 1 h 20 min less than those
without. Also only 50% of individuals used CPAP ≥4 h/
night, compared to 84% of the non-type D personality
[22]. Prospectively, in our study individuals with type D
personality showed no difference in median compliance
compared with non-type D. There was a non-significant
trend towards suboptimal compliance with 33% of individ-
uals with type D personality complying sub-optimally
compared to 22% with non-type D. It is not clear as to
why our results were different than to those of the previ-
ous study. A likely explanation is that previous researchers
looked at the association retrospectively leading to a recall
bias. It is also conceivable that some of the responses to
assess social inhibition and negative affectivity may have
altered over a period of time, particularly with CPAP inter-
vention that potentially can influence mood and behav-
iour. This may have led to a smaller proportion of patients
with type D in the retrospective study (30% vs 45%) and
hence the differences in compliance.
The prevalence of depression as diagnosed by the
GP’s, in our population with OSAS offered CPAP, was
32.7% which is higher than estimates for otherwise unse-
lected primary care patients but similar levels found by
other investigators (32-48%) in people with OSAS [28, 29].
In our study, current symptoms of depression as mea-
sured by a high BDI-2 scores predicted lower compliance
at 6 months. Those with a diagnosis of anxiety were less
likely to comply optimally at first visit and 6 months. De-
pression is known to be associated with poor adherence to
therapy in other chronic medical disorders [30, 31]. In pa-
tients with OSA there is conflicting evidence regarding
any association between underlying depression and CPAP
use. In a prospective study involving 70 patients, there
was no correlation between CPAP compliance at 1 month
and underlying depression measured by the Hospital Anx-
iety and Depression Scale (HADS) scores [32]. In another
study using the Minnesota Multiphasic Personality Inven-
tory to measure depression, individuals who were de-
pressed had poor CPAP compliance compared to those
who were not depressed [33]. A more recent study found
that depression measured on HADS predicted lower Auto
CPAP use at one week (R2 = 0.19, p <0.001) [34]. Un-
employed individuals, compared to those in work, have a
greater chance of poor adherence to chronic medical ther-
apy [35]. They are also more likely to have clinical depres-
sion than employed individuals [36]. However, cause and
effect association is not clearly established. In our study it
is difficult to separate out the effects of depression and un-
employment which frequently occurred in the same
individuals.
To the best of our knowledge this is the first study to
investigate the confidence of a physician in predicting
compliance, when they reviewed the patient for the first
time. There was an association between a physician’s
confidence that the individual would use CPAP and
whether they used it 4 or more hours/night. The differ-
ences observed were not big; however, they support the
hypothesis that a physician can predict CPAP compli-
ance when initiating the treatment. We did not find any
association between the physiological variables of sever-
ity of OSA, ESS score and CPAP compliance, which has
been the experience of other investigators [13, 37, 38].
There are some limitations to the study to consider.
The sample size was determined to give adequate power
primarily for the SEC status comparisons. There are a
number of non-significant trends in the results which
might have been found by chance or could have been
significant in a larger study. The treatment was free for
our subjects but in many health care systems this will
not be the case and income levels may be a dominant
factor. This affects the generalisability of our results.
More than a third of patients seen in clinic did not
consent to participation in the study. This may have
introduced a selection bias, recruiting individuals with a
higher rate of acceptance and compliance but previous
audits of our service have shown very similar rates for
these parameters [39]. The clinicians involved in scoring
the likelihood that subjects would comply with CPAP had
a large range of experience. It is possible that if we had fo-
cussed just on more experienced staff that the predictive
power of the clinician’s impression would have been
greater. This might form the basis of a further study.
In this cohort overall initial acceptance of CPAP was
89.8% which compares favourably with published data.
However, as in other studies a proportion of patients do
not comply well with CPAP. As in other studies early
levels of compliance measured as hours of use was highly
Fig. 3 ROC analysis of physician’s assessment as a predictor of
suboptimal compliance at 6 months
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correlated with long term use (at 6 months). The doctors
prescribing CPAP gave patients who complied poorly a
higher chance of not complying when asked to predict
their usage. People who were long term unemployed
and those with a high score on BDI-2 were less likely
to use CPAP for ≥4 h/night. Socio-economic status,
education level, ESS and ODI did not predict good
and poor compliers.
Conclusions
In our practice there is no significant association between
CPAP compliance with socio-economic status, education
or personality type. Long term unemployed or depressed
individuals were less likely to use CPAP optimally and
may need more intensive support to gain the optimal
benefit from CPAP. Our findings suggest that people who
are long term unemployed and/or currently depressed
should be identified and offered more intensive support
when initiating CPAP therapy to give them the best
chance of getting on with the treatment and achieving the
benefits that it can offer.
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